• Diagnosis​ Info ​and​ ​General​ ​Questions

  CTX001 Continues to Prevent VOCs in People With Severe Disease, Trial Finding

  Posted by Sickle Cell Forum Administrator on January 18, 2021 at 1:54 pm

  

  New trial data find CTX001, a gene-editing cell therapy, safely and effectively raised patients’ fetal hemoglobin levels and stopped vaso-occlusive crises. Read more about it here.

  What do you think of this news?

  Sickle Cell Forum Administrator replied 3 years, 3 months ago 0 Member · 0 Replies
• 0 Replies

Log In to Reply